REG - Craneware plc - Exercise of Share Options

CranewareAnnouncement

07/09/2023 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230907:nRSG7703La&default-theme=true

RNS Number : 7703L  Craneware plc  07 September 2023

Craneware plc

("Craneware" or the "Company")

 

Exercise of Share Options

 

7 September 2023 - The Board of Craneware plc (AIM: CRW.L), the market leader
in automated Value Cycle solutions for the US healthcare market, announces
that on 6 September 2023, Keith Neilson, CEO of the Company, received 12,904
ordinary shares of 1p each in the Company ("Ordinary Shares") following the
exercise of options over 34,472 Ordinary Shares, via the Company's net
settlement* facility.

Following the net* exercise of these share options, Mr. Neilson holds
3,459,443 Ordinary Shares in the capital of the Company, representing 9.80% of
the Company's issued share capital (excluding 243,175 Ordinary Shares held in
treasury).

 

*net of settlement of the exercise cost, income tax and national insurance
contributions

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them:

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Keith Neilson

 

2.   Reason for the notification

a) Position /
status
CEO

b) Initial notification /
Amendment                       Initial notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary Shares of 1p each in the capital of Craneware plc

 

b) Identification
code
ISIN GB00B2425G68

 

c) Nature of the
transaction                                1)
Exercise of options over Ordinary Shares

2) Surrender of Ordinary Shares to satisfy exercise cost and tax liabilities
on share option exercise

 

d) Price(s) and
volume(s)
1) Volume(s) 34,472, Price(s) £3.95

 
2) Volumes(s) 21,568, Price(s) £14.85

 

e) Aggregated
information:

                                    i.
Aggregated volume                1) 34,472

 
2) 21,568

                                    ii.
Price
1) £3.95

 
2) £14.85

 

f) Date of the transaction
           2023-09-06

 

g) Place of the
transaction
Outside a trading venue

 

 

 

 

 

 

For further information, please contact:

 

Craneware
plc
            +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial
PR)
+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara
Verdon
craneware@almapr.co.uk

Peel Hunt (NOMAD and Joint Broker)
 
+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

Investec Bank PLC (Joint
Broker)
+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle
solutions, including 340B management, collaborates with U.S. healthcare
providers to plan, execute, and monitor operational and financial performance
so they can continue to deliver quality care to their communities. Customers
choose The Craneware Group's Trisus data and applications platform as their
key to navigating the journey to financially sustainable value-based care.
Trisus combines revenue integrity, cost management, 340B performance, and
decision enablement into a single, SaaS-based platform. Trisus Chargemaster
secured top ranking in the Chargemaster Management category of the "2023 Best
in KLAS Awards: Software & Services" and is part of an extensive value
cycle management suite. The Craneware Group - transforming the business of
healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUPUBWBUPWGAM